Hanmi Pharm Co Ltd (128940) — Cash Flow-to-Debt Ratio
Hanmi Pharm Co Ltd (128940) has a Cash Flow-to-Debt Ratio of 0.06x as of September 2025, meaning its operating cash flow of ₩42.02 Billion could theoretically repay 0% of its total liabilities (₩694.79 Billion) in one year. See how much free cash does Hanmi Pharm Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hanmi Pharm Co Ltd Cash Flow-to-Debt Ratio (2010–2024)
Historical debt coverage capacity for Hanmi Pharm Co Ltd across 15 annual periods. Also explore 128940 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Hanmi Pharm Co Ltd (2010–2024)
Year-by-year debt coverage analysis for Hanmi Pharm Co Ltd. For market capitalisation and broader financial context, see market value of Hanmi Pharm Co Ltd.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.25x | ₩193.49 Billion | ₩780.09 Billion | ▼ -8.5% |
| 2023 | 0.27x | ₩216.54 Billion | ₩798.46 Billion | ▲ +53.0% |
| 2022 | 0.18x | ₩162.27 Billion | ₩915.36 Billion | ▼ -11.5% |
| 2021 | 0.20x | ₩201.92 Billion | ₩1.01 Trillion | ▲ +38.8% |
| 2020 | 0.14x | ₩151.53 Billion | ₩1.05 Trillion | ▲ +1165.4% |
| 2019 | 0.01x | ₩12.45 Billion | ₩1.09 Trillion | ▼ -60.4% |
| 2018 | 0.03x | ₩25.98 Billion | ₩901.95 Billion | ▲ +139.8% |
| 2017 | -0.07x | ₩-62.91 Billion | ₩868.51 Billion | ▼ -115.1% |
| 2016 | 0.48x | ₩412.97 Billion | ₩862.45 Billion | ▲ +360.3% |
| 2015 | 0.10x | ₩101.71 Billion | ₩977.78 Billion | ▲ +240.8% |
| 2014 | -0.07x | ₩-32.82 Billion | ₩444.09 Billion | ▼ -135.9% |
| 2013 | 0.21x | ₩85.99 Billion | ₩417.95 Billion | ▲ +38.6% |
| 2012 | 0.15x | ₩63.27 Billion | ₩426.25 Billion | ▼ -0.8% |
| 2011 | 0.15x | ₩61.30 Billion | ₩409.53 Billion | ▲ +233.7% |
| 2010 | 0.04x | ₩18.94 Billion | ₩422.34 Billion | — |